Which is a more important risk factor for L-DOPA-induced dyskinesia, age at onset of Parkinson's disease or age at L-DOPA treatment for Parkinson's disease?

被引：0
|
作者：
Kimura, Tamaki [1 ]
Tomiyama, Masahiko [1 ]
Arai, Akira [1 ]
Suzuki, Chieko [1 ]
Shouji, Mikio [1 ]
机构：
[1] Hirosaki Univ, Hirosaki, Aomori, Japan
来源：
NEUROSCIENCE RESEARCH | 2008年 / 61卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S203 / S203
页数：1
相关论文
共 50 条
  • [1] Onset age or age for initial L-dopa treatment: Which is a more important risk factor for L-DOPA-induced dyskinesia in Parkinson's disease?
    Kimura, T.
    Tomiyama, M.
    Arai, A.
    Suzuki, C.
    Kawarabayashi, T.
    Shoji, M.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S118
  • [2] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [3] Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Corsi, Sara
    Scheggi, Simona
    Pardu, Alessandra
    Braccagni, Giulia
    Caruso, Donatella
    Cioffi, Lucia
    Diviccaro, Silvia
    Gentile, Mauro
    Fanni, Silvia
    Stancampiano, Roberto
    Gambarana, Carla
    Melcangi, Roberto Cosimo
    Frau, Roberto
    Carta, Manolo
    EXPERIMENTAL NEUROLOGY, 2023, 363
  • [4] The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
    Huot, Philippe
    Johnston, Tom H.
    Koprich, James B.
    Fox, Susan H.
    Brotchie, Jonathan M.
    PHARMACOLOGICAL REVIEWS, 2013, 65 (01) : 171 - 222
  • [5] mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia
    Sebastianutto, Irene
    Cenci, Maria Angela
    CURRENT OPINION IN PHARMACOLOGY, 2018, 38 : 81 - 89
  • [6] L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's Disease
    Guridi, Jorge
    Obeso, Jose A.
    Rodriguez-Oroz, Maria C.
    Lozano, Andres A.
    Manrique, Miguel
    NEUROSURGERY, 2008, 62 (02) : 311 - 323
  • [7] Animal Models of L-Dopa-Induced Dyskinesia in Parkinson's Disease
    Cenci, M. Angela
    Crossman, Alan R.
    MOVEMENT DISORDERS, 2018, 33 (06) : 889 - 899
  • [8] Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia
    Fiorentini, Chiara
    Savoia, Paola
    Savoldi, Daria
    Missale, Cristina
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (08) : 1101 - 1113
  • [9] Priming for L-dopa-induced dyskinesia in Parkinson's disease: A feature inherent to the treatment or the disease?
    Nadjar, Agnes
    Gerfen, Charles R.
    Bezard, Erwan
    PROGRESS IN NEUROBIOLOGY, 2009, 87 (01) : 1 - 9
  • [10] Molecular mechanism of L-Dopa induced dyskinesia in Parkinson's disease
    Subhani, F. U. -H.
    Subhani, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S119
12345